OncLive
OncLive TV provides short, focused interviews with key oncology thought leaders. This unique platform allows oncology professionals to learn about important developments directly from their peers.
Dr Scarfò on Updated Safety Data With BGB-16673 in Relapsed/Refractory CLL/SLL
Dr Dimopoulos on Elranatamab Plus Daratumumab and Lenalidomide in Myeloma
Dr Curtis on Cyclophosphamide GVHD Prophylaxis in Matched Donor Transplant
Dr Ku on the Safety Profile of JNJ-90014496 in Relapsed/Refractory LBCL
Dr Fathi on the Efficacy and Safety of Ziftomenib in R/R NPM1-Mutant AML
Dr Schetelig on Haploidentical vs Mismatched Transplant Efficacy in AML/ALL/MDS
Dr Dahiya on the Safety Profile of KITE-363 in Relapsed/Refractory B-Cell Lymphoma
Dr Skrypets on an Analysis of Clinical Features of Older Patients With PTCL
Clinical Judgment: Optimal Care vs Selection Bias in Oncology: Episode 1
The Current Financial Reality of Cancer Care in the US: Episode 3
The Current Financial Reality of Cancer Care in the US: Episode 2
The Current Financial Reality of Cancer Care in the US: Episode 1
The Dual Nature of Cancer Treatment: Episode 3
The Dual Nature of Cancer Treatment: Episode 2
The Dual Nature of Cancer Treatment: Episode 1
Ethical Considerations in Cancer Research: Episode 3
Ethical Considerations in Cancer Research: Episode 2
Dr He on the FDA Approval of Nivolumab Plus Ipilimumab for Unresectable/Metastatic HCC
Ethical Considerations in Cancer Research: Episode 1
Hope's Role in Cancer Management: Episode 3
Hope's Role in Cancer Management: Episode 2
Hope's Role in Cancer Management: Episode 1
Clinical Trials in Oncology: Episode 3
Clinical Trials in Oncology: Episode 2
Dr Chiorean on Encorafenib Plus Cetuximab for BRAF V600E–Mutated mCRC
Clinical Trials in Oncology: Episode 1
Prognostic vs Predictive Factors in Oncology: Episode 3
Dr McCann on the Treatment Paradigm for HER2+ Breast Cancer With Brain Metastases
Dr Ahluwalia on the Evolution of Precision Medicine in Oncology
Prognostic vs Predictive Factors in Oncology: Episode 2